Premium
Treating second‐relapsed/refractory first‐relapsed childhood acute myeloid leukaemia: Successful salvage rather than palliation?
Author(s) -
Merli Pietro
Publication year - 2022
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.18140
Subject(s) - refractory (planetary science) , medicine , myeloid leukaemia , salvage therapy , palliative care , myeloid , retrospective cohort study , oncology , pediatrics , chemotherapy , nursing , astrobiology , physics
Prognosis of second‐relapsed/refractory first‐relapsed childhood acute myeloid leukaemia remains poor and there are no clear guidelines on the best treatment approach. The report by White et al. suggests that, while outcomes are still unsatisfactory, there is room to pursue a curative approach rather than palliation. Commentary on: White et al. Clinical outcomes of second relapsed and refractory first relapsed paediatric AML: A retrospective study within the NOPHO‐DB SHIP consortium. Br J Haematol 2022;197:755‐765.